Log-in
Register now
Register now
Log-in

Nordic Life Science Days 2016
14-15 september 2016
Waterfront, Stockholm, Sweden

© 2019 Bionordic. All Rights Reserved

Register now
Log-in

Photo by Miklos Szabo

Register now
Log-in
Log-in

Latest news in cooperation with Nordic Life Science

News

Proposed management changes at Moberg Pharma

15 April 2019 | 7:23 am
Peter Wolpert
The Board of Directors and Nomination Committee have proposed the appointment of Anna Ljung as the new CEO of Moberg Pharma, while current CEO Peter Wolpert will transition to a role as Executive Chairman of the Board of Directors. The divestment of the OTC business on March 29, 2019 represents a significant change for Moberg […]
News

Axel Sjöblad is the new CEO of SenzaGen

15 April 2019 | 7:11 am
Axel Sjöblad
The company’s Board has appointed Axel Sjöblad as the new CEO starting June 17, 2019. Sjöblad most recently held the position as CEO of BioGaia and replaces Anki Malmborg Hager, who after five years as CEO, is nominated to become a member of the company’s board. “We are pleased to welcome Axel Sjöblad as CEO […]
News

BerGenBio extends Phase II trial

12 April 2019 | 6:55 am
Richard Godfrey
The first patient has been dosed in an additional cohort (“Cohort B”) of an ongoing phase II open-label study of BerGenBio’s selective AXL inhibitor bemcentinib in combination with Merck’s anti-PD-1 therapy KEYTRUDA (pembrolizumab) in previously treated patients with advanced adenocarcinoma of the lung (NSCLC). The additional cohort of the BGBC008 trial, being run in collaboration with Merck, […]
News

Zealand Pharma appoints new CEO

12 April 2019 | 6:42 am
Emmanuel Dulac
Emmanuel Dulac will join Zealand Pharma as new Chief Executive Officer on April 22, 2019. Emmanuel Dulac has 25 years of experience in the pharmaceutical industry, with a strong record of commercial and operational leadership underpinned by several senior roles in Europe and North America, reports the company. Since August 2016, Emmanuel has been the […]
News

Mene Pangalos awarded Prix Galien Greece

12 April 2019 | 6:32 am
Mene Pangalos
Mene Pangalos, EVP and President, Research & Development BioPharmaceuticals at AstraZeneca, was awarded the Prix Galien Award Greece on April 11, 2019. The Prix Galien Award is presented to individuals and organisations who have been instrumental in upgrading the quality of, or even saving the lives of patients through the development of innovative drugs and […]
News

Q&A: Matilda Ernkrans, Sweden’s new Minister for Higher Education & Research

11 April 2019 | 8:24 am
Matilda Ernkrans
We asked the new Minister about her goals and efforts when it comes to the country’s life science industry and Sweden’s status as an innovation and scientific research nation. How are you going to make sure that Sweden retains its position as a strong research nation? “We have to provide universities and researchers with the […]
News

LEO Pharma and Elektrofi expand their partnership

10 April 2019 | 9:00 am
Gitte Aabo
The two companies have announced an expansion of their partnership agreement (signed in 2017) to further include antibodies from LEO Pharma’s pipeline with the aim of achieving improvements in drug delivery within dermatology. As part of the agreement LEO Pharma and Elektrofi will initially co-develop two specific antibodies. The agreement includes an option to a […]
News

Genovis collaborates with Thermo Fisher Scientific

10 April 2019 | 8:50 am
Fredrik Olsson
The two companies have entered into a collaboration agreement to develop advanced end-to-end workflows for the preparation, characterization and monitoring of novel and complex biotherapeutics using liquid chromatography-mass spectrometry (LC-MS). The collaborative partnership aims to develop advanced end-to-end methods for the analysis of novel and complex biotherapeutics to meet the increasing demands for high throughput, […]
News

Biovica completes a directed new share issue of SEK 60 million

10 April 2019 | 8:42 am
Anders Rylander
The company has resolved to carry out a directed new share issue of Class B Shares at a subscription price of SEK 10 per share. The directed new share issue was substantially over-subscribed with large interest from institutional investors in the Nordics and Europe. Through the directed new share issue and subject to the approval of […]
News

The Spring issue of our magazine is out now!

10 April 2019 | 8:10 am
Cover NLS 02 2019
Don’t forget to subscribe to our magazine and read inspiring interviews, in-depth stories and articles about the Nordic life science industry’s progress and challenges. This issue is for example filled with inspiring articles about scientists and business leaders, including the new CEO of AstraZeneca Sweden, Katarina Ageborg, and LEO Pharma’s admired CEO, Gitte Aabo. We […]

© 2019 Bionordic. All Rights Reserved

Legal Notices

© 2019 Bionordic. All Rights Reserved

Legal Notices